NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.54
Delayed Data
As of Feb 27
 +0.02 / +3.85%
Today’s Change
0.42
Today|||52-Week Range
1.38
-14.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues510.0K288.0K123.0K152.0K
 
 
 
 
 
Cost of Goods Sold80.0K60.0K18.0K20.0K
 
 
 
 
 
Depreciation And Amortization74.0K70.0K71.0K44.0K
 
 
 
 
 
 
Operating ExpensesGross Income356.0K158.0K34.0K88.0K
 
 
 
 
 
General Expenses5.2M4.2M3.8M4.2M
 
 
 
 
 
Research And Development4.0M2.5M2.2M2.3M
 
 
 
 
 
Total Operating Expenses5.4M4.4M3.9M4.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.9M-4.1M-3.8M-4.1M
 
 
 
 
 
Extraordinary Credit727.0K520.0K797.0K--
 
 
 
 
Extraordinary Charge-------104.0K
 
 
Other Expenses-7.0K-7.0K57.0K-2.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.1M-3.6M-2.9M-4.2M
 
 
 
 
 
Income Taxes-9.0K0.00-10.0K0.00
 
 
 
Net Income-4.1M-3.6M-2.9M-4.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.2M45.3M50.8M50.8M
 
 
 
 
 
Shares To Calculate EPS Diluted41.2M45.3M50.8M50.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.08-$0.06-$0.08
 
 
 
 
 
EPS Diluted-$0.10-$0.08-$0.06-$0.08
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account